ALTEOGEN Statistics

Total Valuation

ALTEOGEN has a market cap or net worth of KRW 14.76 trillion. The enterprise value is 14.71 trillion.

Market Cap	14.76T
Enterprise Value	14.71T

Important Dates

The next estimated earnings date is Monday, March 10, 2025.

Earnings Date	Mar 10, 2025
Ex-Dividend Date	n/a

Share Statistics

ALTEOGEN has 53.30 million shares outstanding. The number of shares has decreased by -0.10% in one year.

Current Share Class	n/a
Shares Outstanding	53.30M
Shares Change (YoY)	-0.10%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	25.87%
Owned by Institutions (%)	10.01%
Float	39.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	196.52
PB Ratio	82.98
P/TBV Ratio	84.18
P/FCF Ratio	747.42
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5,061.37
EV / Sales	197.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	744.73

Financial Position

The company has a current ratio of 8.84, with a Debt / Equity ratio of 0.04.

Current Ratio	8.84
Quick Ratio	8.35
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	0.60
Interest Coverage	-7.20

Financial Efficiency

Return on equity (ROE) is -2.01% and return on invested capital (ROIC) is -1.37%.

Return on Equity (ROE)	-2.01%
Return on Assets (ROA)	-1.26%
Return on Capital (ROIC)	-1.37%
Revenue Per Employee	512.93M
Profits Per Employee	-20.04M
Employee Count	145
Asset Turnover	0.26
Inventory Turnover	39.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +283.13% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+283.13%
50-Day Moving Average	354,880.00
200-Day Moving Average	275,166.00
Relative Strength Index (RSI)	37.56
Average Volume (20 Days)	1,067,660

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ALTEOGEN had revenue of KRW 74.38 billion and -2.91 billion in losses. Loss per share was -73.02.

Revenue	74.38B
Gross Profit	32.15B
Operating Income	-5.70B
Pretax Income	-5.06B
Net Income	-2.91B
EBITDA	-2.76B
EBIT	-5.70B
Loss Per Share	-73.02

Full Income Statement

Balance Sheet

The company has 153.72 billion in cash and 11.77 billion in debt, giving a net cash position of 141.95 billion or 2,663.46 per share.

Cash & Cash Equivalents	153.72B
Total Debt	11.77B
Net Cash	141.95B
Net Cash Per Share	2,663.46
Equity (Book Value)	266.10B
Book Value Per Share	3,338.28
Working Capital	148.46B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 21.65 billion and capital expenditures -1.90 billion, giving a free cash flow of 19.75 billion.

Operating Cash Flow	21.65B
Capital Expenditures	-1.90B
Free Cash Flow	19.75B
FCF Per Share	370.61

Full Cash Flow Statement

Margins

Gross margin is 43.22%, with operating and profit margins of -7.66% and -3.91%.

Gross Margin	43.22%
Operating Margin	-7.66%
Pretax Margin	-6.81%
Profit Margin	-3.91%
EBITDA Margin	-3.71%
EBIT Margin	-7.66%
FCF Margin	26.56%

Dividends & Yields

ALTEOGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.10%
Shareholder Yield	0.10%
Earnings Yield	-0.03%
FCF Yield	0.13%

Stock Splits

The last stock split was on October 25, 2022. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 25, 2022
Split Type	Forward
Split Ratio	1.2

Scores

ALTEOGEN has an Altman Z-Score of 168.82.

Altman Z-Score	168.82
Piotroski F-Score	n/a